Effects of melanocortin 1 receptor agonists in experimental nephropathies

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Lindskog Jonsson, Annika ^a   Granqvist, Anna ^a   Elvin, Johannes ^a   Johansson, Martin E ^b   Haraldsson, Börje ^a   Nyström, Jenny ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; BMS 470539; DOXORUBICIN; MELANOCORTIN 1 RECEPTOR; MELANOCORTIN RECEPTOR AGONIST; MS 05; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DRUG EFFICACY; DRUG WITHDRAWAL; FOCAL GLOMERULOSCLEROSIS; HEYMANN NEPHRITIS; HUMAN; HUMAN CELL; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MOUSE; NONHUMAN; PODOCYTE; PROTEINURIA; RAT; SIGNAL TRANSDUCTION;

ALBUMINURIA; ANIMALS; DISEASE MODELS, ANIMAL; DOXORUBICIN; GLOMERULONEPHRITIS, MEMBRANOUS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; IMIDAZOLES; MALE; MICE; MICE, INBRED BALB C; PROTEINURIA; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, MELANOCORTIN, TYPE 1;

EID: 84900443972     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087816     Document Type: Article

References (31)

1. Beck LH Jr. (2010) Membranous nephropathy and malignancy. Semin Nephrol 30: 635-644.
2. Farquhar MG, Saito A, Kerjaschki D, Orlando RA (1995) The Heymann nephritis antigenic complex: megalin (gp330) and RAP. J Am Soc Nephrol 6: 35-47.
3. Wei C, El Hindi S, Li J, Fornoni A, Goes N, et al. (2011) Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 17: 952-960.
4. D'Agati VD (2012) Pathobiology of focal segmental glomerulosclerosis: new developments. Curr Opin Nephrol Hypertens 21: 243-250.
5. Meyrier A (2005) Mechanisms of disease: focal segmental glomerulosclerosis. Nature clinical practice Nephrology 1: 44-54.
6. Chugh SS, Clement LC, Mace C (2012) New insights into human minimal change disease: lessons from animal models. Am J Kidney Dis 59: 284-292.
7. Ishimoto T, Shimada M, Araya CE, Huskey J, Garin EH, et al. (2011) Minimal change disease: a CD80 podocytopathy? Semin Nephrol 31: 320-325.
8. KDIGO (2012) Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney Int Suppl. 2: 139-274.
9. Berg AL, Arnadottir M (2004) ACTH-induced improvement in the nephrotic syndrome in patients with a variety of diagnoses. Nephrol Dial Transplant 19: 1305-1307.
10. Berg AL, Nilsson-Ehle P, Arnadottir M (1999) Beneficial effects of ACTH on the serum lipoprotein profile and glomerular function in patients with membranous nephropathy. Kidney Int 56: 1534-1543. (Pubitemid 29451260)
11. Ponticelli C, Passerini P, Salvadori M, Manno C, Viola BF, et al. (2006) A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy. Am J Kidney Dis 47: 233-240. (Pubitemid 43121326)
12. Lindskog A, Ebefors K, Johansson ME, Stefansson B, Granqvist A, et al. (2010) Melanocortin 1 receptor agonists reduce proteinuria. Journal of the American Society of Nephrology : JASN 21: 1290-1298.
13. Mundel P, Reiser J (2010) Proteinuria: an enzymatic disease of the podocyte? Kidney Int 77: 571-580.
14. Salant DJ, Cybulsky AV (1988) Experimental glomerulonephritis. Methods Enzymol 162: 421-461. (Pubitemid 19019528)
15. Wang Y, Wang YP, Tay YC, Harris DC (2000) Progressive adriamycin nephropathy in mice: sequence of histologic and immunohistochemical events. Kidney Int 58: 1797-1804.
16. Lee VW, Harris DC (2011) Adriamycin nephropathy: a model of focal segmental glomerulosclerosis. Nephrology 16: 30-38.
17. Pippin JW, Brinkkoetter PT, Cormack-Aboud FC, Durvasula RV, Hauser PV, et al. (2009) Inducible rodent models of acquired podocyte diseases. American journal of physiology Renal physiology 296: F213-229.
18. Dai C, Stolz DB, Kiss LP, Monga SP, Holzman LB, et al. (2009) Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria. Journal of the American Society of Nephrology : JASN 20: 1997-2008.
19. Guo J, Ananthakrishnan R, Qu W, Lu Y, Reiniger N, et al. (2008) RAGE mediates podocyte injury in adriamycin-induced glomerulosclerosis. Journal of the American Society of Nephrology : JASN 19: 961-972.
20. Crowley SD, Vasievich MP, Ruiz P, Gould SK, Parsons KK, et al. (2009) Glomerular type 1 angiotensin receptors augment kidney injury and inflammation in murine autoimmune nephritis. The Journal of clinical investigation 119: 943-953.
21. Szardenings M, Muceniece R, Mutule I, Mutulis F, Wikberg JE (2000) New highly specific agonistic peptides for human melanocortin MC(1) receptor. Peptides 21: 239-243. (Pubitemid 30182487)
22. Herpin TF, Yu G, Carlson KE, Morton GC, Wu X, et al. (2003) Discovery of tyrosine-based potent and selective melanocortin-1 receptor small-molecule agonists with anti-inflammatory properties. J Med Chem 46: 1123-1126. (Pubitemid 36428217)
23. Kang L, McIntyre KW, Gillooly KM, Yang Y, Haycock J, et al. (2006) A selective small molecule agonist of the melanocortin-1 receptor inhibits lipopolysaccharide-induced cytokine accumulation and leukocyte infiltration in mice. J Leukoc Biol 80: 897-904. (Pubitemid 44835908)
24. Leoni G, Voisin MB, Carlson K, Getting S, Nourshargh S, et al. (2010) The melanocortin MC(1) receptor agonist BMS-470539 inhibits leucocyte trafficking in the inflamed vasculature. Br J Pharmacol 160: 171-180.
25. Bjornson A, Moses J, Ingemansson A, Haraldsson B, Sorensson J (2005) Primary human glomerular endothelial cells produce proteoglycans, and puromycin affects their posttranslational modification. Am J Physiol Renal Physiol 288: F748-756. (Pubitemid 40381742)
26. Jeansson M, Haraldsson B (2003) Glomerular size and charge selectivity in the mouse after exposure to glucosaminoglycan-degrading enzymes. J Am Soc Nephrol 14: 1756-1765. (Pubitemid 36750471)
27. Mundel P, Reiser J, Zuniga Mejia Borja A, Pavenstadt H, Davidson GR, et al. (1997) Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 236: 248-258. (Pubitemid 27452369)
28. Daehn I, Zhang T, Casalena G, Fenninger F, Böttinger EP (2011) Role of Endothelin-1 in Podocyte-to-Endothelial Cross-Talk in Podocytopathies. American Society of Nephrology annual meeting: Kidney Week, Philadelphia FR-OR297.
29. Sun YB, Qu X, Zhang X, Caruana G, Bertram JF, et al. (2013) Glomerular endothelial cell injury and damage precedes that of podocytes in adriamycin-induced nephropathy. PLoS One 8: e55027.
30. Jackson IJ, Budd PS, Keighren M, McKie L (2007) Humanized MC1R transgenic mice reveal human specific receptor function. Hum Mol Genet 16: 2341-2348. (Pubitemid 47423900)
31. Mountjoy KG, Robbins LS, Mortrud MT, Cone RD (1992) The cloning of a family of genes that encode the melanocortin receptors. Science 257: 1248-1251.